ADTECH PHARMA

adtech-pharma-logo

Adtech is an innovative biotech firm that has developed a novel formulation of a sole-sourced synthetic cannabinoid therapeutic targeting glaucoma. The company was founded in 2021 and is based in Warwick, Rhode Island, United States.

#SimilarOrganizations #People #Financial #Website #More

ADTECH PHARMA

Industry:
Biopharma Biotechnology Health Care

Founded:
2021-01-01

Address:
Warwick, Rhode Island, United States

Country:
United States

Website Url:
http://www.adtechpharma.com

Status:
Closed

Contact:
401-623-1434

Total Funding:
5.98 M USD

Technology used in webpage:
U.S. Server Location


Similar Organizations

arbutus-biopharma-logo

Arbutus Biopharma

Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.

cyteir-therapeutics-logo

Cyteir Therapeutics

Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

metis-therapeutics-logo

METiS Therapeutics

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

smartpharm-therapeutics-logo

SmartPharm Therapeutics

SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.

Current Employees Featured

robert-kupper_image

Robert Kupper
Robert Kupper President and CEO @ Adtech Pharma
President and CEO

Founder


robert-kupper_image

Robert Kupper

Investors List

ault-global-holdings_image

Ault Global Holdings

Ault Global Holdings investment in Corporate Round - Adtech Pharma

Official Site Inspections

http://www.adtechpharma.com

  • Host name: 217.67.109.208.host.secureserver.net
  • IP address: 208.109.67.217
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Adtech Pharma"

Management – Adtech Pharma, Inc.

Management Adtech Pharma, Inc. Robert Kupper, PhD President and CEO Robert Kupper, PhD, is Adtech’s President and CEO, and was formerly with the National Institute of Health, WR …See details»

Adtech Pharma - Crunchbase Company Profile & Funding

Adtech is an innovative biotech firm that has developed a novel formulation of a sole-sourced synthetic cannabinoid therapeutic targeting glaucoma.See details»

Contact Us – Adtech Pharma, Inc.

Contact Us Adtech Pharma, Inc.See details»

Adtech Pharma 2025 Company Profile: Valuation, Funding

Adtech Pharma General Information Description. Developer of a sole-sourced synthetic cannabinoid therapeutic designed to target glaucoma. The company eliminates the issue of …See details»

Adtech Pharma - Products, Competitors, Financials, Employees ...

Ault Global Holdings Announces Adtech Pharma, Inc., an Innovative Biotech, Appoints Jodi Brichan to Its Board of Directors. Sep 27, 2021. September 27, 2021 06:30 AM Eastern …See details»

Adtech Pharma, Inc. - Drug pipelines, Patents, Clinical trials

Explore Adtech Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Nervous System Diseases, Endocrinology and Metabolic ...See details»

Adtech Pharma - The Org

Adtech is an innovative biotech firm that has developed a novel formulation of a sole-sourced synthetic cannabinoid therapeutic targeting glaucoma.The company was founded in 2021 and …See details»

Adtech Pharma - VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»

Adtech Pharma Inc - Company Profile and News - Bloomberg …

Company profile page for Adtech Pharma Inc including stock price, company news, executives, board members, and contact informationSee details»

Adtech Pharma - 2025 Company Profile & Competitors - Tracxn

Jan 27, 2025 Developer of ophthalmic solution for glaucoma. The lead candidate NB-110 comprises synthetic cannabinoid nabilone which mimics human tear. It enables delivery …See details»

Adtech Pharma, Inc. (Adtech Pharma, Inc.) - 药物管线_专利_临床试 …

了解Adtech Pharma, Inc. (Adtech Pharma, Inc.)公司的药物管线,治疗领域,技术平台,以及它的1篇新闻,疾病领域:神经系统疾病,内分泌与代谢疾病,技术平台:小分子化药,药物:大麻隆。See details»

Our Treatment - Adtech Pharma, Inc.

Our Treatment Adtech Pharma, Inc. Drug Candidate (NB-110): what is it and how does it work NB-110 is a novel ophthalmic formulation comprising a synthetic cannabinoid Nabilone in the …See details»

Adtech Pharma CEO, Founder, Key Executive Team, Board of …

Explore {Adtech Pharma's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

Adtech Pharma Stock Data, Filings, Earnings, News & Transcripts

Get the latest news, data and filings for Adtech Pharma, with free alerts. Includes transcripts, social sentiment, and more.See details»

Adtech Pharma - Company Profile

Adtech is an innovative biotech firm that has developed a novel formulation of a sole-sourced synthetic cannabinoid therapeutic targeting glaucoma. The company was founded in 2021 and …See details»

Adtech Pharma company profile - app.employbl.com

Adtech is an innovative biotech firm that has developed a novel formulation of a sole-sourced synthetic cannabinoid therapeutic targeting glaucoma. The company was founded in 2021 and …See details»

Ault Global Holdings Announces Agreement to Acquire up to 40

Jun 28, 2021 LAS VEGAS--(BUSINESS WIRE)--Ault Global Holdings, Inc. (NYSE American: DPW) a diversified holding company (the “Company”), announced it has entered into a …See details»

Glaucoma - Adtech Pharma, Inc.

Glaucoma Open-Angle Glaucoma The angle where the iris meets the cornea are as wide and open as should be, but the trabecular meshwork is partially blocked causing pressure to …See details»

My account – Adtech Pharma, Inc.

With scientific innovation, fulfill medical needs and build shareholder valueSee details»

linkstock.net © 2022. All rights reserved